[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@zhaoweiasu Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::191281008.png) @zhaoweiasu Wei Zhao

Wei Zhao posts on X about $edits, elements, $wve006, $beam302 the most. They currently have XXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::191281008/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::191281008/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX +34%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +43%

### Mentions: X [#](/creator/twitter::191281008/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::191281008/c:line/m:posts_active.svg)

- X Month XX -XX%
- X Months XX -XX%
- X Year XXX +103%

### Followers: XXXXX [#](/creator/twitter::191281008/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::191281008/c:line/m:followers.svg)

- X Week XXXXX +0.43%
- X Month XXXXX +3.30%
- X Months XXXXX +22%
- X Year XXXXX +38%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::191281008/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::191281008/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::191281008/influence)
---

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[$edits](/topic/$edits) 12.5%, [elements](/topic/elements) 12.5%, [$wve006](/topic/$wve006) 12.5%, [$beam302](/topic/$beam302) 12.5%, [$crsp](/topic/$crsp) 12.5%, [$beam](/topic/$beam) 12.5%, [$prme](/topic/$prme) 12.5%, [all the](/topic/all-the) XXXX%

**Top accounts mentioned or mentioned by**
[@geneinvesting](/creator/undefined) [@biopharmiq](/creator/undefined) [@matarener](/creator/undefined) [@vega_n1](/creator/undefined) [@yaireinhorn](/creator/undefined) [@crisprtx](/creator/undefined) [@crisprsam](/creator/undefined) [@capitalusher](/creator/undefined) [@crisprspace](/creator/undefined) [@xfinancialx](/creator/undefined) [@rnaianalyst](/creator/undefined)

**Top assets mentioned**
[CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [BEAM (BEAM)](/topic/$beam)
### Top Social Posts [#](/creator/twitter::191281008/posts)
---
Top posts by engagements in the last XX hours

"$EDIT's bold move (different from PCSK9/ANGPTL3 knockdown) ➡ Dual guide RNA to delete regulatory elements in the 3' UTR ➡ Upregulates LDLR in the liver by 6X and drove XX% LDL-C lowering in animals (preclinical) ❓ Big question: in humans how low LDL-C should we goand whats the right target for lifelong risk reduction"  
[X Link](https://x.com/zhaoweiasu/status/1978595274768687122) [@zhaoweiasu](/creator/x/zhaoweiasu) 2025-10-15T22:54Z 6563 followers, 3127 engagements


"Base editing corrects SERPINA1-E342K mutation for alpha-1 antitrypsin deficiency (AATD). "This landmark result in medicine represents the first clinical evidence of precise correction of a disease-causing mutation by rewriting the genetic code." -- John Evans CEO of Beam Therapeutics"  
[X Link](https://x.com/zhaoweiasu/status/1980431050741555424) [@zhaoweiasu](/creator/x/zhaoweiasu) 2025-10-21T00:28Z 6563 followers, 1482 engagements


"AATD $WVE-006 vs $BEAM-302 ➡200 mg MAD (Q2W) vs XX mg single dose ➡Total AAT: XXXX vs XXXX M ➡M-AAT: XX% (peak) vs XX% (day 28) ➡Reduction in Z-AAT: -XXXX% (peak) vs -XX% (day 28) 🚨Conclusion: BEAM-302 is superior in every metric Note: Unlike WVE-006 BEAM-302 shows a clear dose response and has higher dose data coming (75mg and 60mg x 2) early next year"  
[X Link](https://x.com/zhaoweiasu/status/1963283436451602783) [@zhaoweiasu](/creator/x/zhaoweiasu) 2025-09-03T16:50Z 6559 followers, 9369 engagements


"@yaireinhorn @CRISPRTX @CrisprSam Classical misleading statements by $CRSP. Base editing is not saturating at 12uM as $BEAM has not yet reported the 4th dose data. Prime editing was invented by David Liu's lab in 2019 and "SyNTase editing" is clearly copying it"  
[X Link](https://x.com/zhaoweiasu/status/1977783527480623558) [@zhaoweiasu](/creator/x/zhaoweiasu) 2025-10-13T17:08Z 6563 followers, 1221 engagements


"@GeneInvesting People like @capital_usher and @crisprspace are clearly more bullish on $PRME than you. They have been supporting it all the time"  
[X Link](https://x.com/zhaoweiasu/status/1980795575428870390) [@zhaoweiasu](/creator/x/zhaoweiasu) 2025-10-22T00:37Z 6564 followers, XXX engagements


"AAV Gene Therapy Scoreboard (2025) 1Eye (Luxturna) ✅ Success. Local subretinal injection XXX XX vg/eye. Tiny immune-privileged space; minimal systemic exposure. 2Ear (OTOF) ✅ Early success. Local cochlear injection; low dose with minimal systemic exposure. 3Local brain (Huntingtons AMT-130) ✅ Encouraging. Direct infusion into striatum; bypasses the BBB. (Recent topline shows slowing of progression in high-dose cohort.) 4Systemic brain (Capsida CAP-002) ⚠ Trial paused after a patient death; investigation ongoing. IV delivery (1010 vg/kg) aims for brain-wide reach but broad systemic exposure is"  
[X Link](https://x.com/zhaoweiasu/status/1977466153665696230) [@zhaoweiasu](/creator/x/zhaoweiasu) 2025-10-12T20:07Z 6563 followers, 7703 engagements


"@GeneInvesting You cannot say you spend more time on BEAM and PRME than I do. In fact you already lost track on BEAM"  
[X Link](https://x.com/zhaoweiasu/status/1981090324681544142) [@zhaoweiasu](/creator/x/zhaoweiasu) 2025-10-22T20:08Z 6564 followers, XXX engagements